United States - English - NLM (National Library of Medicine)

bausch & lomb incorporated - bacitracin zinc (unii: 89y4m234es) (bacitracin - unii:58h6rwo52i), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k) - bacitracin 500 [usp'u] in 1 g - for the treatment of superficial ocular infections involving the conjunctiva and/or cornea caused by organisms susceptible to bacitracin zinc and polymyxin b sulfate. this product is contraindicated in those individuals who have shown hypersensitivity to any of its components.

United States - English - NLM (National Library of Medicine)

padagis us llc - bacitracin (unii: 58h6rwo52i) (bacitracin - unii:58h6rwo52i) - bacitracin 500 [usp'u] in 1 g - for the treatment of superficial ocular infections involving the conjunctiva and/or cornea caused by bacitracin susceptible organisms. this product should not be used in patients with a history of hypersensitivity to bacitracin.

United States - English - NLM (National Library of Medicine)

rebel distributors corp - bacitracin (unii: 58h6rwo52i) (bacitracin - unii:58h6rwo52i) - bacitracin 500 [iu] in 1 g - for the treatment of superficial ocular infections involving the conjunctiva and/or cornea caused by bacitracin susceptible organisms. this product should not be used in patients with a history of hypersensitivity to bacitracin.

United States - English - NLM (National Library of Medicine)

stratus pharmaceuticals inc - bacitracin zinc (unii: 89y4m234es) (bacitracin - unii:58h6rwo52i), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k) - bacitracin 500 [usp'u] in 1 g - first aid to help prevent infection in - minor cuts - scrapes - burns

United States - English - NLM (National Library of Medicine)

trifecta pharmaceuticals usa, llc. - bacitracin zinc (unii: 89y4m234es) (bacitracin - unii:58h6rwo52i) - bacitracin 500 [usp'u] in 1 g - first aid antibiotic first aid to help prevent infection in - minor cuts - scrapes - burns - the condition persists or gets worse - a rash or allergic reaction develops

United States - English - NLM (National Library of Medicine)

phoenix global supply group, inc - bacitracin zinc (unii: 89y4m234es) (bacitracin zinc - unii:89y4m234es) - bacitracin zinc 500 [iu] in 1 g - first aid antibiotic first aid to help prevent infection in minor: - cuts - scrapes - burns

United States - English - NLM (National Library of Medicine)

rebel distributors corp - bacitracin zinc (unii: 89y4m234es) (bacitracin - unii:58h6rwo52i), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k) - bacitracin zinc 500 in 1 g - this product is contraindicated in those individuals who have shown hypersensitivity to any of its components.

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - bacitracin (unii: 58h6rwo52i) (bacitracin - unii:58h6rwo52i) - bacitracin 500 [iu] in 1 g - for the treatment of superficial ocular infections involving the conjunctiva and/or cornea caused by bacitracin susceptible organisms. this product should not be used in patients with a history of hypersensitivity to bacitracin.

United States - English - NLM (National Library of Medicine)

cosette pharmaceuticals, inc. - bacitracin (unii: 58h6rwo52i) (bacitracin - unii:58h6rwo52i) - bacitracin 500 [usp'u] in 1 g - first aid antibiotic first aid to help prevent infection in minor cuts, scrapes and burns

United States - English - NLM (National Library of Medicine)

x-gen pharmaceuticals, inc. - bacitracin (unii: 58h6rwo52i) (bacitracin - unii:58h6rwo52i) - bacitracin 50000 [usp'u] - in accord with the statements in the “warning box” the use of intramuscular bacitracin is limited to the treatment of infants with pneumonia and empyema caused by staphylococci shown to be susceptible to the drug. to reduce the development of drug-resistant bacteria and maintain the effectiveness of bacitracin and other antibacterial drugs, bacitracin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. this drug is contraindicated in those individuals with a history of previous hypersensitivity or toxic reaction to it.